A Study of IBI353 (Orismilast) in Chinese Healthy Adults

Clinical trial NCT05490316 · COMPLETED

Trial details

NCT number: NCT05490316
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2022-11-30
Primary completion: 2022-11-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.